
SELECT 2
@SELECT2Trial
Followers
285
Following
35
Media
4
Statuses
32
Official Twitter Account for the SELECT 2 Randomized Controlled Trial. #Stroke #EVT #SELECT2 #LargeCore
Joined August 2020
RT @amrsarrajMD: Great visits with @SELECT2Trial PIs in Spain @marcriboj @jordiblascoa @ArenillasJF @perecardonag @natperezossa TY @hbellviβ¦.
0
4
0
RT @amrsarrajMD: Our latest from SELECT @GreenJournal :CTP core estimate (rCBF<30%) correlated significantly with F/U MRI infarct volume. Oβ¦.
0
9
0
RT @amrsarrajMD: Great visits to @SELECT2Trial Barcelona sites @vallhebron @hospitalclinic Thank you to my co-investigators @marcriboj @jorβ¦.
0
5
0
RT @amrsarrajMD: Great visit @SELECT2Trial Barcelona site @hbellvitge Excellent research infrastructure and dedicated investigators! Thankβ¦.
0
6
0
We are grateful for the excellent work from our tram @GoodmanCampbell Thank you @AmuluruKrishna and the wonderful research tram for helping us to advance patients care.
Our first SELECT2 trial recruitment; wake-up stroke with a right ICA occlusion, ASPECT 4, randomized to thrombectomy. One pass TICI3 recanalization. Thank you to our amazing research team!. #Stroke #EndovascularNeurosurgery #SELECT2 #NoELVOLeftBehind
0
1
5
We are grateful for the excellent work from our team @TJUHNeurosurg Congratulations on your enrollments, many more to come! @PascalJabbourMD @NabeelHerial @StavTjoumakaris and all the wonderful fellows.
Proud of our fellows and research coordinators ππ»ππ» Recent enrollements by @PascalJabbourMD and @chenjared placed @TJUHospital at Top 5 enroller globally in @SELECT2Trial. Strong work ππ»ππ»πͺπ» @StavTjoumakaris @ReidGooch @FadiAlSaieghMD @chenjared @Moh_Shehabeldin @rolandjabre
0
2
10
RT @Fie0815: @MeyerL_MD: EVT not superior in ASPECTS 0-5 LVO stroke in 1:1 pair matching of real-life data (π©πͺ stroke registry). https://t.β¦.
0
11
0
RT @PascalJabbourMD: When you are a top 5 enroller in @SELECT2Trial you get a visit from the national PI @amrsarrajMD π! @NabeelHerial @Staβ¦.
0
2
0
RT @amrsarrajMD: You bet @PascalJabbourMD ! Amazing researchers @PascalJabbourMD @StavTjoumakaris @NabeelHerial and excellent site @TJUHNeuβ¦.
0
5
0
RT @amrsarrajMD: Workflow optimization and judicious selection for direct to Angio result in faster reperfusion and may improve #thrombectoβ¦.
0
16
0
RT @amrsarrajMD: Latest SELECT paper @GreenJournal Bridging with tPA had better outcomes than direct EVT, driven by milder strokes (NIHSS<1β¦.
neurology.org
ObjectiveTo evaluate the comparative safety and efficacy of direct endovascular thrombectomy (dEVT) compared to bridging therapy (BT; IV tissue plasminogen activator + EVT) and to assess whether BT...
0
36
0
RT @shazamhussain: Itβs important to know the data behind the study. Honored to work with fantastic colleagues in the @SELECT2Trial .@Ameβ¦.
0
7
0
Grateful for the late Saturday night enrollment @TJUHNeurosurg Fellows leading the charge @TTheofanis with the maestro @PascalJabbourMD Way to go team! @NabeelHerial @StavTjoumakaris #NoLVOleftbehind.
4
3
13
RT @ArenillasJF: Thank you to Ana, Isabel, Javier, Bea and Jorge for enrolling our 2nd #stroke patient in @SELECT2Trial at #HCUV #teamworkβ¦.
0
4
0
What a wonderful team at #HCUV Second patient in a week! Way to go team! Felicidades! Mas, mas!.
Thank you to Ana, Isabel, Javier, Bea and Jorge for enrolling our 2nd #stroke patient in @SELECT2Trial at #HCUV #teamwork @MercedesLera @javireyesmunoz @MaryEstherRamos @DoctorGaldamez @JorgeGalvan7 @drschuller ππΌππΌππΌππΌ
0
1
3
Welcome aboard Valladolid!! Thank you Patricia, Juan and team for the wonderful work enrolling in the late night hours! Way more to come!! #NoLVOleftbehind @amrsarrajMD.
Our first patient enrolled in @SELECT2Trial at #HCUV !! #stroke π§ #teamwork πͺπ» #firstpatient ππ».@ArenillasJF @DoctorGaldamez
0
3
15
RT @amrsarrajMD: Thrombectomy/ICH year in review:EVT in basilars(BASILAR/BEST),EVT in low income countries(RESILIENT)@sheilambrasil,Infieldβ¦.
0
9
0
RT @StrokeAHA_ASA: #STROKE Early Infarct Growth Rate strongly correlates with both collateral status and clinical outcomes after #Mechanicaβ¦.
0
13
0